LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
CRMD CorMedix
- 10.360
- +0.110+1.07%
Close Feb 28 16:00 ET
- 10.360
- 0.0000.00%
Post 20:01 ET
628.62MMarket Cap-12.95P/E (TTM)
10.510High10.100Low1.61MVolume10.240Open10.250Pre Close16.73MTurnover2.69%Turnover RatioLossP/E (Static)60.68MShares13.85052wk High10.70P/B621.65MFloat Cap3.03052wk Low--Dividend TTM60.00MShs Float52.000Historical High--Div YieldTTM4.00%Amplitude0.729Historical Low10.364Avg Price1Lot Size
CorMedix News
CorMedix | SCHEDULE 13G/A: Others
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Todisco Joseph
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director DUNTON ALAN W
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Stewart Robert A
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Dillione Janet
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Kaplan Myron
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Lefkowitz Steven W
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Duncan Gregory Scott
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer David Matthew T
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Todisco Joseph
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Mistry Erin
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Hurlburt Elizabeth
CorMedix | 8-K: CorMedix Inc. announces preliminary Fourth quarter 2024 results and provides business update
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Mistry Erin
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Hurlburt Elizabeth
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer David Matthew T
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Zelnick Kaufman Beth
CorMedix | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Zelnick Kaufman Beth
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Zelnick Kaufman Beth
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Mistry Erin
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!